or Try an Advanced Search...

    Pharmaceuticals Segment Stocks List

    Symbol Grade Name % Change
    XPH B SPDR S&P Pharmaceuticals ETF 2.29
    PRGO C Perrigo Company 0.37
    NVO D Novo Nordisk A/S -2.11
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Diabetes Diabetes Care Hormones Pharmaceutical Products Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Cough Dietary Supplement ETF Endocrine System Exchange Traded Fund Feminine Hygiene Gastrointestinal Generic Drug Glucagon Like Peptide 1 Growth Hormone

    Related ETFs - A few ETFs which own one or more of the above listed Pharmaceuticals Segment stocks.

    Symbol Grade Name Weight
    OZEM F Roundhill GLP-1 & Weight Loss ETF 17.04
    THNR F Amplify Weight Loss Drug & Treatment ETF 13.16
    PPH D Market Vectors Pharmaceutical ETF 8.18
    BELT B BlackRock Long-Term U.S. Equity ETF 5.28
    AADR A WCM BNY Mellon Focused Growth ADR ETF 4.85
    View all Pharmaceuticals Segment ETFs...
    Compare ETFs
    Compare BELT to AADR Compare OZEM to AADR Compare OZEM to THNR

        Pharmaceuticals Segment Stocks Recent News

        Date Stock Title
        Nov 21 NVO Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU
        Nov 21 NVO Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
        Nov 20 NVO More companies covering weight loss drugs for their employees
        Nov 20 NVO Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
        Nov 20 NVO Is Novo Nordisk Stock a Buy Right Now?
        Nov 20 NVO RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead.
        Nov 19 NVO Novo Nordisk semaglutide phase 3 trial for MASH meets primary endpoints
        Nov 19 NVO Sector Update: Health Care Stocks Decline
        Nov 19 NVO Novo Nordisk Unusual Options Activity For November 19
        Nov 19 NVO Sector Update: Health Care Stocks Mixed Tuesday Afternoon
        Nov 19 NVO Novo Erases 2024 Gain, Wiping Out $210 Billion in Value
        Nov 19 NVO Market Chatter: Eli Lilly, Novo Nordisk Press Employers to Cover the Cost of Weight-Loss Drugs
        Nov 19 PRGO Perrigo Company: Great Combination Of Future Growth With A Low Valuation
        Nov 19 NVO Employers Get Pressure to Pay for Drugs Like Wegovy
        Nov 18 NVO RFK Jr.'s HHS nomination sparks concern over pharma stocks
        Nov 18 NVO Novo Nordisk reportedly launches Wegovy in China
        Nov 18 NVO How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health
        Nov 18 NVO Market Chatter: Eli Lilly, Novo Nordisk Obesity Drugs Covered Mostly by Medicaid, Analysts Say
        Nov 18 NVO Exclusive: Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
        Nov 17 XPH Hedge funds were net buyers of financials, healthcare for week: Goldman Sachs
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Diabetes Diabetes Care Hormones Pharmaceutical Products Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Cough Dietary Supplement ETF Endocrine System Exchange Traded Fund Feminine Hygiene Gastrointestinal Generic Drug Glucagon Like Peptide 1 Growth Hormone
        Pharmaceuticals Segment

        Pharmaceuticals segment is a sector of the healthcare industry that focuses on the research, development, production, and marketing of drugs and other pharmaceutical products. This segment includes companies that manufacture and distribute prescription and over-the-counter drugs, as well as those that provide related services such as contract manufacturing and clinical research.

        Browse All Tags